For patients with rheumatic disease and hepatitis C infection: the end of interferon

Hepatitis C virus (HCV) is a global pathogen and is the cause of rare but complex rheumatic complications but more commonly exists as a challenging comorbidity for patients with existing rheumatic diseases. Until recently, the standard of care of HCV has been the use of interferon-based regimens, wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Calabrese, Leonard H, Cacoub, Patrice P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613164/
https://www.ncbi.nlm.nih.gov/pubmed/26509045
http://dx.doi.org/10.1136/rmdopen-2014-000008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613164/
https://www.ncbi.nlm.nih.gov/pubmed/26509045
http://dx.doi.org/10.1136/rmdopen-2014-000008

Ejemplares similares